Mark J. Alles - Insider Trading & Ownership

Entity
Individual
Location
C/O Celgene Corporation, 86 Morris Avenue, Summit, NJ
Summary
The estimated net worth of Mark J. Alles is at least $1.48M dollars as of September 19, 2023. Mark J. Alles is the Director of BIOMARIN PHARMACEUTICAL INC and owns shares of BIOMARIN PHARMACEUTICAL INC (BMRN) stock worth about $1.45M. Mark J. Alles is the Director of Syros Pharmaceuticals, Inc. and owns shares of Syros Pharmaceuticals, Inc. (SYRS) stock worth about $28K.
All Insider Reports
All Insider Reports

Ownership of Mark J. Alles

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BMRN BIOMARIN PHARMACEUTICAL INC Director $1.45M May 23, 2023
SYRS Syros Pharmaceuticals, Inc. Director $28K Sep 16, 2023
TPTX Turning Point Therapeutics, Inc. Director Aug 17, 2022

Insider Transactions Reported by Mark J. Alles:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.